Texas-based juice brand Buda Juice raises $20 million pricing IPO at $7.50, the low end of the range
IPO Overview
Buda Juice, which makes branded and private label citrus drinks, raised $20 million by offering 2.7 million shares at $7.50, the low end of the range of $7.50 to $9.00.
Buda Juice states that it is pioneering the “UltraFresh” juice category through its end-to-end cold chain platform. Based in Dallas, Texas, its product portfolio consists of fresh citrus juices and wellness shots across multiple brand lines and retail customers, which it believes demonstrates both brand diversification and private label manufacturing capabilities. The company currently operates from its Dallas plant but has plans for facilities in South Carolina （2026） and Arizona/Nevada （2027）。
Buda Juice plans to list on the NYSE American under the symbol BUDA. MDB Capital Group acted as sole bookrunner on the deal.
About the Company
Buda Juice is pioneering the UltraFresh juice category through our end-to-end cold chain platform that delivers always cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. We bridge the gap between shelf-stable products and operationally challenging in-store juicing, enabling any retailer to offer truly fresh and safe juice without infrastructure investment or operational complexity. We have validated our model through strong financial performance, growing revenue from $5.6 million in 2022 to $11.2 million in 2024, representing a 41.8% CAGR. Currently operating from our Dallas plant, we are executing a disciplined geographic expansion strategy with planned facilities in South Carolina （2026） and Arizona/Nevada （2027）， enabling us to serve a large percentage of the U.S. population. Our product portfolio consists of fresh citrus juice, fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using our cold chain process. Our product portfolio demonstrates both brand diversification and private label manufacturing capabilities, allowing us to serve multiple market segments while leveraging our core cold chain production platform. The organic wellness shots represent our premium positioning, and our conventional fresh citrus juices, fresh citrus-based line of lemonades and private label offerings provide broader market access and volume scale in the UltraFresh category.